Direct Answer
Dialysis centers treat patients with kidney failure, who need blood cleaning several times a week for life. Most patients are covered by Medicare, while commercial insurance pays far higher rates and supplies most of the profit.
Industry Overview
Dialysis Centers sits within the health care sector. The first numbers to compare across companies here are treatments per day and volume growth, revenue per treatment and commercial payer mix. The outside forces that move them are listed under Primary Macro Drivers.
Key Industry Metrics
- Treatments per day and volume growth: Number of dialysis sessions delivered and its growth rate. Because patients need regular sessions, volume moves slowly, and a dip can reflect fewer patients or missed treatments.
- Revenue per treatment: Average payment received per dialysis session. It blends low government rates and higher commercial rates, so small shifts in payer mix or rate updates can change profit materially.
- Commercial payer mix: Share of patients covered by private insurance rather than Medicare. Commercial plans pay far above Medicare rates, so even a small decline in this share can weigh heavily on profit.
- Patient census and mortality: Number of patients treated and the rate at which patients die or leave care. Census growth is limited by mortality, so the net change shows whether new patient starts exceed losses.
- Clinic operating margin: Profit at clinic level after staff, supplies and drugs. Because Medicare rates are set by rule, margin moves with commercial mix, labor costs and clinic utilization.
Primary Macro Drivers
- Prevalence of diabetes and kidney disease: More people with diabetes and kidney disease means more patients who need ongoing treatment, supporting treatments per day and patient census.
- Medicare end-stage renal disease payment rules: Medicare sets a bundled payment per treatment for most patients, so each annual update changes revenue per treatment and clinic margin.
- Commercial contract rates: Commercial plans pay much more per treatment, so contract renewals and the share of commercially insured patients move profit more than volume.
- Use of newer diabetes drugs that may slow kidney disease: Drugs that slow kidney damage might delay the need for dialysis, which would lower new patient starts over time; watch patient census growth.
Major Risks
- Government payment changes: Cuts or changes to the bundled payment reduce revenue per treatment, and most profit comes from a small commercial share; watch final payment rules.
- Patient volume impact from new drugs: If new drugs delay patients reaching dialysis, treatment volume growth slows; watch new patient starts and treatments per day against prior trends.
- Labor costs: Nurses and technicians are the main cost, so wage increases and shortages raise cost per treatment unless payments rise too.
- Concentration in two large providers: Two providers treat most patients, so a policy or contract change that hits one of them affects the whole industry; watch payer and policy disclosures.
Industry Characteristics
| Characteristic | Profile |
|---|---|
| Cyclicality | Defensive |
| Capital Intensity | Medium |
| Regulatory Intensity | High |
| Industry Maturity | Mature |
| Geographic Importance | U.S. |
Companies Associated with Dialysis Centers
The SEC's Standard Industrial Classification has no code that describes dialysis centers as a group, so there is no complete list of its filers. The companies below come from Swoopr's SEC dataset and have operations in or next to the industry. Each is classified by the SEC under its own main business.
| Company | SEC classification | Revenue | Growth | Net margin | Year |
|---|---|---|---|---|---|
| Davita Inc. | Services-Misc Health & Allied Services, Nec | $13.6 billion | 6.5% | 7.9% | FY 2025 |
Source: each company's own annual report as filed with the SEC (XBRL data), figures in U.S. dollars. Listing here describes a business relationship to the industry, not a recommendation. To find more companies, use the company directory and the health care hub.
Where to Go Next
The Dialysis Centers guide describes how the industry earns money, what to measure and what can go wrong. To see how it compares, read the neighbouring industries in the same sector, then apply the same checks to a specific company.
More in Health Care
- Health Care sector overview
- Digital Therapeutics
- Diagnostics & Post-Acute Care
- Drug Discovery Platforms
- Diagnostic Laboratories
- Electronic Health Records
- Diagnostic Devices
- European Pharmaceuticals
- Diabetes Devices
Put it to work
Frequently Asked Questions
What are the main KPIs for the Dialysis Centers industry?
Key performance indicators for the Dialysis Centers industry include: Treatments per day and volume growth, Revenue per treatment, Commercial payer mix, Patient census and mortality, Clinic operating margin. Which matter most depends on the company's model, so compare them across several companies rather than relying on one.
How cyclical is the Dialysis Centers industry?
The Dialysis Centers industry is generally defensive, meaning demand tends to remain relatively stable regardless of the economic cycle. Companies in this space can provide portfolio stability during recessions, though growth may lag in strong expansions.
What are the biggest risks in the Dialysis Centers industry?
The primary risks for Dialysis Centers companies include: Government payment changes, Patient volume impact from new drugs, Labor costs, Concentration in two large providers. Investors should assess each company's exposure to these factors and its track record of navigating them.